Foamy Combinatorial Anti-HIV Vectors with MGMTP140K Potently Inhibit HIV-1 and SHIV Replication and Mediate Selection In Vivo

[1]  Christopher Baum,et al.  Protein scaffold and expression level determine antiviral activity of membrane-anchored antiviral peptides. , 2008, Human gene therapy.

[2]  M. Amarzguioui,et al.  Engineering and optimization of the mir-106b-cluster for ectopic expression of multiplexed anti-HIV RNAs , 2008, Gene Therapy.

[3]  H. Kiem,et al.  NOD/SCID repopulating cells contribute only to short-term repopulation in the baboon , 2008, Gene Therapy.

[4]  J. Fletcher,et al.  Efficient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors. , 2008, Blood.

[5]  Ben Berkhout,et al.  Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition , 2008, Molecular Therapy.

[6]  R. Sékaly.  The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? , 2008, The Journal of experimental medicine.

[7]  John J Rossi,et al.  Genetic therapies against HIV , 2007, Nature Biotechnology.

[8]  David Baltimore,et al.  Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates , 2007, Proceedings of the National Academy of Sciences.

[9]  F Xiao-Feng Qin,et al.  Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  A. Schambach,et al.  Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus , 2006, Gene Therapy.

[11]  A. Schambach,et al.  Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression , 2006, Gene Therapy.

[12]  Hans-Peter Kiem,et al.  Foamy virus vector integration sites in normal human cells , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Calvin M. Johnson,et al.  Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs. , 2005, Virology.

[14]  Hans-Peter Kiem,et al.  Hematopoietic stem cell transduction and amplification in large animal models. , 2005, Human gene therapy.

[15]  T. Neff,et al.  Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy. , 2005, Blood.

[16]  M. Kotb,et al.  Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2Rγnull Mice Engrafted with Mobilized Human Hemopoietic Stem Cells 12 , 2004, The Journal of Immunology.

[17]  D. Russell,et al.  Transduction of long-term and mobilized peripheral blood-derived NOD/SCID repopulating cells by foamy virus vectors. , 2004, Human gene therapy.

[18]  S. Cole,et al.  Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. , 2004, Human gene therapy.

[19]  Richard Carroll,et al.  Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  S. Ngoi,et al.  Exploiting internal ribosome entry sites in gene therapy vector design. , 2004, Current gene therapy.

[21]  Renate Kunert,et al.  Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides , 2004, Journal of Virology.

[22]  David A. Williams,et al.  Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model. , 2003, The Journal of clinical investigation.

[23]  S. Gerson,et al.  In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning. , 2003, The Journal of clinical investigation.

[24]  B. Ramratnam,et al.  Human Immunodeficiency Virus Type 1 Escape from RNA Interference , 2003, Journal of Virology.

[25]  J. Rossi,et al.  Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  A. Carr.  Toxicity of antiretroviral therapy and implications for drug development , 2003, Nature Reviews Drug Discovery.

[27]  Yiming Shao,et al.  Enhanced: The Need for a Global HIV Vaccine Enterprise , 2003, Science.

[28]  G. Vassilopoulos,et al.  Improved foamy virus vectors with minimal viral sequences. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[29]  J. Warren.  Preclinical AIDS vaccine research: survey of SIV, SHIV, and HIV challenge studies in vaccinated nonhuman primates , 2002, Journal of medical primatology.

[30]  Michael S Saag,et al.  Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. , 2002, JAMA.

[31]  B. Wood,et al.  Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Ali Ehsani,et al.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells , 2002, Nature Biotechnology.

[33]  Thomas Tuschl,et al.  Expanding small RNA interference , 2002, Nature Biotechnology.

[34]  D. Lindemann,et al.  Improved Primate Foamy Virus Vectors and Packaging Constructs , 2002, Journal of Virology.

[35]  G. Vassilopoulos,et al.  Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors. , 2001, Blood.

[36]  J. Church,et al.  Gene Therapy for Pediatric AIDS , 2000, Annals of the New York Academy of Sciences.

[37]  R. Morgan,et al.  Potent inhibition of human immunodeficiency virus type 1 replication by conditionally replicating human immunodeficiency virus-based lentiviral vectors expressing envelope antisense mRNA. , 2000, Human gene therapy.

[38]  A. Trkola,et al.  A Cell Line-Based Neutralization Assay for Primary Human Immunodeficiency Virus Type 1 Isolates That Use either the CCR5 or the CXCR4 Coreceptor , 1999, Journal of Virology.

[39]  L. Naldini,et al.  Interaction of Human Immunodeficiency Virus-Derived Vectors with Wild-Type Virus in Transduced Cells , 1999, Journal of Virology.

[40]  D. Carbonaro,et al.  A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children. , 1999, Blood.

[41]  A. Pegg,et al.  Isolation of human O6-alkylguanine-DNA alkyltransferase mutants highly resistant to inactivation by O6-benzylguanine. , 1998, Cancer research.

[42]  P. Luciw,et al.  Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection , 1997, Journal of virology.

[43]  Marc Parmentier,et al.  Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.

[44]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[45]  J. Levy.  The value of primate models for studying human immunodeficiency virus pathogenesis , 1996, Journal of medical primatology.

[46]  H. McClure,et al.  Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques , 1996, Journal of virology.

[47]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Pegg,et al.  Mutations in human O6-alkylguanine-DNA alkyltransferase imparting resistance to O6-benzylguanine. , 1994, Cancer research.

[49]  H. Friedman,et al.  An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1 , 1992, Journal of virology.

[50]  C. Kimpton,et al.  A further tetranucleotide repeat polymorphism in the vWF gene. , 1992, Human molecular genetics.

[51]  H. Zentgraf,et al.  Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene. , 1991, Virology.

[52]  B. Cullen,et al.  Characterization of the transcriptional trans activator of human foamy retrovirus , 1991, Journal of virology.

[53]  R. Flügel,et al.  Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes. , 1987, The EMBO journal.

[54]  J. Hooks,et al.  The foamy viruses. , 1975, Bacteriological reviews.

[55]  D. Russell,et al.  Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[56]  D. Kohn,et al.  Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[57]  D. Russell,et al.  Foamy-virus-mediated gene transfer to canine repopulating cells. , 2007, Blood.

[58]  Felix Hermann,et al.  Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[59]  P. Cresswell,et al.  Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids , 2004, Immunogenetics.

[60]  M. Schweizer,et al.  Replication of primate foamy viruses in natural and experimental hosts. , 2003, Current topics in microbiology and immunology.

[61]  G. Vassilopoulos,et al.  Gene transfer with foamy virus vectors. , 2002, Methods in enzymology.

[62]  N. Nathanson,et al.  The role of nonhuman primates in the development of an AIDS vaccine. , 1999, AIDS.

[63]  R. Flügel.  Spumaviruses: a group of complex retroviruses. , 1991, Journal of acquired immune deficiency syndromes.

[64]  Flügel Rm.  Spumaviruses: a group of complex retroviruses. , 1991 .